Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0)

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 28-11-2023, 23:46